The [RNQ+] prion: A model of both functional and pathological amyloid

Prion

Volumn 5, Issue 4, 2011, Pages 291-298

  Stein, Kevin C ^a   True, Heather L ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

PSI+ ; RNQ+ ; Chaperones; Epigenetic; Functional amyloid; Polyglutamine; Prion; Toxic amyloid

Indexed keywords

AMYLOID; CHAPERONE; HEAT SHOCK PROTEIN 40; HEAT SHOCK PROTEIN 70; POLYGLUTAMINE; PRION PROTEIN; RNQ1 PROTEIN; SIS1P PROTEIN; SUP35P PROTEIN; UNCLASSIFIED DRUG;

[PSI+]; [RNQ+] PRION; [URE3]; ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; AMYLOID NEUROPATHY; CYTOTOXICITY; GENE OVEREXPRESSION; MISSENSE MUTATION; NERVE DEGENERATION; NONHUMAN; PRION; PRION DISEASE; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN DEFECT; PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; YEAST;

AMYLOID; MODELS, MOLECULAR; MOLECULAR CHAPERONES; PRIONS; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS;

EID: 83755178155     PISSN: 19336896     EISSN: 1933690X     Source Type: Journal    
DOI: 10.4161/pri.5.4.18213     Document Type: Review

References (113)

1. Chiti F, Dobson CM. Protein misfolding, functional amyloid and human disease. Annu Rev Biochem 2006; 75:333-66. (Pubitemid 44118036)
2. Soto C, Estrada L, Castilla J. Amyloids, prions and the inherent infectious nature of misfolded protein aggregates. Trends Biochem Sci 2006; 31:150-5. (Pubitemid 43357995)
3. Colby DW, Prusiner SB. Prions. Cold Spring Harb Perspect Biol 2011; 3:6833.
4. Fowler DM, Koulov AV, Balch WE, Kelly JW. Functional amyloid - from bacteria to humans. Trends Biochem Sci 2007; 32:217-24. (Pubitemid 46694328)
5. Tuite MF, Serio TR. The prion hypothesis: from biological anomaly to basic regulatory mechanism. Nat Rev Mol Cell Biol 2010; 11:823-33.
6. Shewmaker F, McGlinchey RP, Wickner RB. Structural insights into functional and pathological amyloid. J Biol Chem 2011; 286:16533-40.
7. Patino MM, Liu JJ, Glover JR, Lindquist S. Support for the prion hypothesis for inheritance of a phenotypic trait in yeast. Science 1996; 273:622-6. (Pubitemid 26262109)
8. +] determinant is mediated by oligomerization of the SUP35-encoded polypeptide chain release factor. EMBO J 1996; 15:3127-34.
9. True HL, Lindquist SL. A yeast prion provides a mechanism for genetic variation and phenotypic diversity. Nature 2000; 407:477-83.
10. True HL, Berlin I, Lindquist SL. Epigenetic regulation of translation reveals hidden genetic variation to produce complex traits. Nature 2004; 431:184-7. (Pubitemid 39243470)
11. Eaglestone SS, Cox BS, Tuite MF. Translation termination efficiency can be regulated in Saccharomyces cerevisiae by environmental stress through a prion-mediated mechanism. EMBO J 1999; 18:1974-81. (Pubitemid 29158540)
12. Masel J, Bergman A. The evolution of the evolvability properties of the yeast prion [PSI+]. Evolution Int J Org Evolution 2003; 57:1498-512. (Pubitemid 36953639)
13. Masel J. Cryptic genetic variation is enriched for potential adaptations. Genetics 2006; 172:1985-91.
14. Giacomelli MG, Hancock AS, Masel J. The conversion of 3' UTRs into coding regions. Mol Biol Evol 2007; 24:457-64.
15. +]. Genetics 2009; 181:1057-63.
16. +] system. Genetics 2010; 184:393-400.
17. Wickner RB. [URE3] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisiae. Science 1994; 264:566-9. (Pubitemid 24185861)
18. +] prion in Saccharomyces cerevisiae. Genetics 1997; 147:507-19.
19. Derkatch IL, Bradley ME, Masse SV, Zadorsky SP, Polozkov GV, Inge-Vechtomov SG, et al. Dependence and independence of [PSI(+)] and [PIN(+)]: A two-prion system in yeast? EMBO J 2000; 19:1942-52. (Pubitemid 30237570)
20. Derkatch IL, Bradley ME, Hong JY, Liebman SW. Prions affect the appearance of other prions: the story of [PIN(+)]. Cell 2001; 106:171-82. (Pubitemid 32772628)
21. Osherovich LZ, Weissman JS. Multiple Gln/Asn-rich prion domains confer susceptibility to induction of the yeast [PSI(+)] prion. Cell 2001; 106:183-94. (Pubitemid 32772629)
22. Bradley ME, Edskes HK, Hong JY, Wickner RB, Liebman SW. Interactions among prions and prion "strains" in yeast. Proc Natl Acad Sci USA 2002; 99:16392-9. (Pubitemid 35470984)
23. +] are diseases. Proc Natl Acad Sci USA 2005; 102:10575-80.
24. Resende CG, Outeiro TF, Sands L, Lindquist S, Tuite MF. Prion protein gene polymorphisms in Saccharomyces cerevisiae. Mol Microbiol 2003; 49: 1005-17. (Pubitemid 36981345)
25. Sondheimer N, Lindquist S. Rnq1: an epigenetic modifier of protein function in yeast. Mol Cell 2000; 5:163-72. (Pubitemid 30105445)
26. Bruce KL, Chernoff YO. Sequence specificity and fidelity of prion transmission in yeast. Semin Cell Dev Biol 2011; In press.
27. +]. J Mol Biol 2007; 365:773-82.
28. +] prion reveals stability of amyloid fibers as the key determinant of yeast prion variant propagation. J Biol Chem 2010; 285:20748-55.
29. +] prion, has a parallel in-register beta-sheet structure. Proc Natl Acad Sci USA 2008; 105:2403-8.
30. King CY, Diaz-Avalos R. Protein-only transmission of three yeast prion strains. Nature 2004; 428:319-23. (Pubitemid 38418802)
31. Tanaka M, Chien P, Naber N, Cooke R, Weissman JS. Conformational variations in an infectious protein determine prion strain differences. Nature 2004; 428:323-8. (Pubitemid 38418803)
32. Collinge J, Clarke AR. A general model of prion strains and their pathogenicity. Science 2007; 318:930-6. (Pubitemid 350098981)
33. Derkatch IL, Chernoff YO, Kushnirov VV, Inge-Vechtomov SG, Liebman SW. Genesis and variability of [PSI] prion factors in Saccharomyces cerevisiae. Genetics 1996; 144:1375-86. (Pubitemid 26427888)
34. Schlumpberger M, Prusiner SB, Herskowitz I. Induction of distinct [URE3] yeast prion strains. Mol Cell Biol 2001; 21:7035-46. (Pubitemid 32911263)
35. Dobson CM. Protein misfolding, evolution and disease. Trends Biochem Sci 1999; 24:329-32. (Pubitemid 29421804)
36. Zoghbi HY, Orr HT. Glutamine repeats and neurodegeneration. Annu Rev Neurosci 2000; 23:217-47. (Pubitemid 30350043)
37. Vitrenko YA, Pavon ME, Stone SI, Liebman SW. Propagation of the [PIN+] prion by fragments of Rnq1 fused to GFP. Curr Genet 2007; 51:309-19. (Pubitemid 46605319)
38. +] prion. EMBO J 2001; 20:2435-42.
39. Douglas PM, Treusch S, Ren HY, Halfmann R, Duennwald ML, Lindquist S, et al. Chaperonedependent amyloid assembly protects cells from prion toxicity. Proc Natl Acad Sci USA 2008; 105:7206-11. (Pubitemid 351754456)
40. Bardill JP, Dulle JE, Fisher JR, True HL. Requirements of Hsp104p activity and Sis1p binding for propagation of the [RNQ(+)] prion. Prion 2009; 3:151-60.
41. Shibata S, Kurahashi H, Nakamura Y. Localization of prion-destabilizing mutations in the N-terminal non-prion domain of Rnq1 in Saccharomyces cerevisiae. Prion 2009; 3:250-8.
42. Kurahashi H, Pack CG, Shibata S, Oishi K, Sako Y, Nakamura Y. [PSI(+)] aggregate enlargement in rnq1 nonprion domain mutants, leading to a loss of prion in yeast. Genes Cells 2011; 16:576-89.
43. Bardill JP, True HL. Heterologous prion interactions are altered by mutations in the prion protein Rnq1p. J Mol Biol 2009; 388:583-96.
44. DePace AH, Santoso A, Hillner P, Weissman JS. A critical role for amino-terminal glutamine/asparagine repeats in the formation and propagation of a yeast prion. Cell 1998; 93:1241-52. (Pubitemid 28307428)
45. Osherovich LZ, Cox BS, Tuite MF, Weissman JS. Dissection and design of yeast prions. PLoS Biol 2004; 2:86.
46. Tank EM, Harris DA, Desai AA, True HL. Prion protein repeat expansion results in increased aggregation and reveals phenotypic variability. Mol Cell Biol 2007; 27:5445-55. (Pubitemid 47124397)
47. Kalastavadi T, True HL. Prion protein insertional mutations increase aggregation propensity but not fiber stability. BMC Biochem 2008; 9:7.
48. Parham SN, Resende CG, Tuite MF. Oligopeptide repeats in the yeast protein Sup35p stabilize intermolecular prion interactions. EMBO J 2001; 20:2111-9. (Pubitemid 32410581)
49. Kadnar ML, Articov G, Derkatch IL. Distinct type of transmission barrier revealed by study of multiple prion determinants of Rnq1. PLoS Genet 2010; 6:1000824.
50. Morimoto RI. Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging. Genes Dev 2008; 22:1427-38. (Pubitemid 351793077)
51. True HL. The battle of the fold: chaperones take on prions. Trends Genet 2006; 22:110-7. (Pubitemid 43152030)
52. Summers DW, Douglas PM, Cyr DM. Prion propagation by Hsp40 molecular chaperones. Prion 2009; 3:59-64.
53. Masison DC, Kirkland PA, Sharma D. Influence of Hsp70s and their regulators on yeast prion propagation. Prion 2009; 3:65-73.
54. Glover JR, Lindquist S. Hsp104, Hsp70 and Hsp40: a novel chaperone system that rescues previously aggregated proteins. Cell 1998; 94:73-82. (Pubitemid 28347471)
55. Tipton KA, Verges KJ, Weissman JS. In vivo monitoring of the prion replication cycle reveals a critical role for Sis1 in delivering substrates to Hsp104. Mol Cell 2008; 32:584-91.
56. Shorter J, Lindquist S. Hsp104 catalyzes formation and elimination of self-replicating Sup35 prion conformers. Science 2004; 304:1793-7. (Pubitemid 38787894)
57. Shorter J, Lindquist S. Destruction or potentiation of different prions catalyzed by similar Hsp104 remodeling activities. Mol Cell 2006; 23:425-38. (Pubitemid 44128844)
58. Inoue Y, Taguchi H, Kishimoto A, Yoshida M. Hsp104 binds to yeast Sup35 prion fiber but needs other factor(s) to sever it. J Biol Chem 2004; 279:52319-23. (Pubitemid 39656606)
59. +]. Science 1995; 268:880-4.
60. Higurashi T, Hines JK, Sahi C, Aron R, Craig EA. Specificity of the J-protein Sis1 in the propagation of 3 yeast prions. Proc Natl Acad Sci USA 2008; 105:16596-601.
61. Moriyama H, Edskes HK, Wickner RB. [URE3] prion propagation in Saccharomyces cerevisiae: requirement for chaperone Hsp104 and curing by overexpressed chaperone Ydj1p. Mol Cell Biol 2000; 20:8916-22. (Pubitemid 32245922)
62. Kirkland PA, Reidy M, Masison DC. Functions of yeast Hsp40 chaperone Sis1p dispensable for prion propagation but important for prion curing and protection from prion toxicity. Genetics 2011; 188:565-77.
63. Kurahashi H, Nakamura Y. Channel mutations in Hsp104 hexamer distinctively affect thermotolerance and prion-specific propagation. Mol Microbiol 2007; 63:1669-83. (Pubitemid 46426708)
64. +] seeds necessary for prion propagation. EMBO J 2007; 26:3794-803.
65. Lopez N, Aron R, Craig EA. Specificity of class II Hsp40 Sis1 in maintenance of yeast prion [RNQ(+)]. Mol Biol Cell 2003; 14:1172-81. (Pubitemid 36337461)
66. Summers DW, Douglas PM, Ren HY, Cyr DM. The type I Hsp40 Ydj1 utilizes a farnesyl moiety and zinc finger-like region to suppress prion toxicity. J Biol Chem 2009; 284:3628-39.
67. Cheetham ME, Caplan AJ. Structure, function and evolution of DnaJ: conservation and adaptation of chaperone function. Cell Stress Chaperones 1998; 3:28-36. (Pubitemid 28159676)
68. Lu Z, Cyr DM. The conserved carboxyl terminus and zinc finger-like domain of the co-chaperone Ydj1 assist Hsp70 in protein folding. J Biol Chem 1998; 273:5970-8. (Pubitemid 28124078)
69. Aron R, Lopez N, Walter W, Craig EA, Johnson J. In vivo bipartite interaction between the Hsp40 Sis1 and Hsp70 in Saccharomyces cerevisiae. Genetics 2005; 169:1873-82. (Pubitemid 40695604)
70. Sindi SS, Serio TR. Prion dynamics and the quest for the genetic determinant in protein-only inheritance. Curr Opin Microbiol 2009; 12:623-30.
71. Mathur V, Hong JY, Liebman SW. Ssa1 overexpression and [PIN(+)] variants cure [PSI(+)] by dilution of aggregates. J Mol Biol 2009; 390:155-67.
72. +] prion in yeast and aggregation of Sup35 in vitro. Proc Natl Acad Sci USA 2004; 101:12934-9.
73. Bagriantsev S, Liebman SW. Specificity of prion assembly in vivo. J Biol Chem 2004; 279:51042-8.
74. Derkatch IL, Liebman SW. Prion-prion interactions. Prion 2007; 1:161-9.
75. +] prion in yeast. Proc Natl Acad Sci USA 2010; 107:6394-9.
76. Namy O, Galopier A, Martini C, Matsufuji S, Fabret C, Rousset JP. Epigenetic control of polyamines by the prion [PSI(+)]. Nat Cell Biol 2008.
77. Wickner RB, Edskes HK, Shewmaker F, Nakayashiki T. Prions of fungi: inherited structures and biological roles. Nat Rev Microbiol 2007; 5:611-8. (Pubitemid 47074116)
78. Wickner RB, Edskes HK, Shewmaker F, Nakayashiki T, Engel A, McCann L, et al. Yeast prions: evolution of the prion concept. Prion 2007; 1:94-100.
79. Namy O, Duchateau-Nguyen G, Rousset JP. Translational readthrough of the PDE2 stop codon modulates cAMP levels in Saccharomyces cerevisiae. Mol Microbiol 2002; 43:641-52. (Pubitemid 34597259)
80. Kryndushkin DS, Engel A, Edskes H, Wickner RB. Molecular chaperone Hsp104 can promote yeast prion generation. Genetics 2011; 188:339-48.
81. 2+/CaM-dependent phosphatase (calcineurin) is improved by mutations in URE2 or PMA1. Genetics 1998; 149:865-78.
82. +] prion aggregates are formed by small Sup35 polymers fragmented by Hsp104. J Biol Chem 2003.
83. Uptain SM, Sawicki GJ, Caughey B, Lindquist S. Strains of [PSI(+)] are distinguished by their efficiencies of prion-mediated conformational conversion. EMBO J 2001; 20:6236-45. (Pubitemid 33078697)
84. Toyama BH, Kelly MJ, Gross JD, Weissman JS. The structural basis of yeast prion strain variants. Nature 2007; 449:233-7. (Pubitemid 47402368)
85. Tanaka M, Collins SR, Toyama BH, Weissman JS. The physical basis of how prion conformations determine strain phenotypes. Nature 2006; 442:585-9. (Pubitemid 44167919)
86. Angers RC, Kang HE, Napier D, Browning S, Seward T, Mathiason C, et al. Prion strain mutation determined by prion protein conformational compatibility and primary structure. Science 2010; 328:1154-8.
87. Legname G, Nguyen HO, Baskakov IV, Cohen FE, Dearmond SJ, Prusiner SB. Strain-specified characteristics of mouse synthetic prions. Proc Natl Acad Sci USA 2005; 102:2168-73. (Pubitemid 40262030)
88. Bradley ME, Liebman SW. Destabilizing interactions among [PSI(+)] and [PIN(+)] yeast prion variants. Genetics 2003; 165:1675-85. (Pubitemid 38040262)
89. Vitrenko YA, Gracheva EO, Richmond JE, Liebman SW. Visualization of aggregation of the Rnq1 prion domain and cross-seeding interactions with Sup35NM. J Biol Chem 2007; 282:1779-87. (Pubitemid 47076692)
90. Salnikova AB, Kryndushkin DS, Smirnov VN, Kushnirov VV, Ter-Avanesyan MD. Nonsense suppression in yeast cells overproducing Sup35 (eRF3) is caused by its non-heritable amyloids. J Biol Chem 2005; 280:8808-12. (Pubitemid 40409569)
91. Schwimmer C, Masison DC. Antagonistic interactions between yeast [PSI(+)] and [URE3] prions and curing of [URE3] by Hsp70 protein chaperone Ssa1p but not by Ssa2p. Mol Cell Biol 2002; 22:3590-8. (Pubitemid 34525203)
92. Kurahashi H, Ishiwata M, Shibata S, Nakamura Y. A regulatory role of the Rnq1 nonprion domain for prion propagation and polyglutamine aggregates. Mol Cell Biol 2008; 28:3313-23. (Pubitemid 351657095)
93. Kurahashi H, Shibata S, Ishiwata M, Nakamura Y. Selfish prion of Rnq1 mutant in yeast. Genes Cells 2009; 14:659-68.
94. Krobitsch S, Lindquist S. Aggregation of huntingtin in yeast varies with the length of the polyglutamine expansion and the expression of chaperone proteins. Proc Natl Acad Sci USA 2000; 97:1589-94. (Pubitemid 30118486)
95. Meriin AB, Zhang X, He X, Newnam GP, Chernoff YO, Sherman MY. Huntington toxicity in yeast model depends on polyglutamine aggregation mediated by a prion-like protein Rnq1. J Cell Biol 2002; 157:997-1004. (Pubitemid 34839774)
96. Gokhale KC, Newnam GP, Sherman MY, Chernoff YO. Modulation of prion-dependent polyglutamine aggregation and toxicity by chaperone proteins in the yeast model. J Biol Chem 2005; 280:22809-18. (Pubitemid 40853187)
97. Muchowski PJ, Schaffar G, Sittler A, Wanker EE, Hayer-Hartl MK, Hartl FU. Hsp70 and hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils. Proc Natl Acad Sci USA 2000; 97:7841-6. (Pubitemid 30460735)
98. Goehler H, Droge A, Lurz R, Schnoegl S, Chernoff YO, Wanker EE. Pathogenic polyglutamine tracts are potent inducers of spontaneous Sup35 and Rnq1 amyloidogenesis. PLoS One 2010; 5:9642.
99. Urakov VN, Vishnevskaya AB, Alexandrov IM, Kushnirov VV, Smirnov VN, Ter-Avanesyan MD. Interdependence of amyloid formation in yeast: implications for polyglutamine disorders and biological functions. Prion 2010; 4:45-52.
100. Duennwald ML, Jagadish S, Giorgini F, Muchowski PJ, Lindquist S. A network of protein interactions determines polyglutamine toxicity. Proc Natl Acad Sci USA 2006; 103:11051-6. (Pubitemid 44148416)
101. Duennwald ML, Jagadish S, Muchowski PJ, Lindquist S. Flanking sequences profoundly alter polyglutamine toxicity in yeast. Proc Natl Acad Sci USA 2006; 103:11045-50. (Pubitemid 44148415)
102. Meriin AB, Zhang X, Miliaras NB, Kazantsev A, Chernoff YO, McCaffery JM, et al. Aggregation of expanded polyglutamine domain in yeast leads to defects in endocytosis. Mol Cell Biol 2003; 23: 7554-65. (Pubitemid 37271456)
103. Meriin AB, Zhang X, Alexandrov IM, Salnikova AB, Ter-Avanesian MD, Chernoff YO, et al. Endocytosis machinery is involved in aggregation of proteins with expanded polyglutamine domains. FASEB J 2007; 21:1915-25. (Pubitemid 46855636)
104. Wang Y, Meriin AB, Costello CE, Sherman MY. Characterization of proteins associated with polyglutamine aggregates: a novel approach towards isolation of aggregates from protein conformation disorders. Prion 2007; 1:128-35.
105. Manogaran AL, Hong JY, Hufana J, Tyedmers J, Lindquist S, Liebman SW. Prion formation and polyglutamine aggregation are controlled by two classes of genes. PLoS Genet 2011; 7:1001386.
106. Derkatch IL, Bradley ME, Liebman SW. Overexpression of the SUP45 gene encoding a Sup35p-binding protein inhibits the induction of the de novo appearance of the [PSI+] prion. Proc Natl Acad Sci USA 1998; 95: 2400-5. (Pubitemid 28145953)
107. Vishveshwara N, Bradley ME, Liebman SW. Sequestration of essential proteins causes prion associated toxicity in yeast. Mol Microbiol 2009; 73:1101-14.
108. Douglas PM, Summers DW, Ren HY, Cyr DM. Reciprocal efficiency of RNQ1 and polyglutamine detoxification in the cytosol and nucleus. Mol Biol Cell 2009; 20:4162-73.
109. Fan CY, Ren HY, Lee P, Caplan AJ, Cyr DM. The type I Hsp40 zinc finger-like region is required for Hsp70 to capture non-native polypeptides from Ydj1. J Biol Chem 2005; 280:695-702. (Pubitemid 40165037)
110. Li J, Qian X, Sha B. The crystal structure of the yeast Hsp40 Ydj1 complexed with its peptide substrate. Structure 2003; 11:1475-83. (Pubitemid 37510348)
111. Berthelot K, Ta HP, Gean J, Lecomte S, Cullin C. In vivo and in vitro analyses of toxic mutants of HET-s: FTIR antiparallel signature correlates with amyloid toxicity. J Mol Biol 2011; 412:137-52.
112. Mitchell-Olds T, Willis JH, Goldstein DB. Which evolutionary processes influence natural genetic variation for phenotypic traits? Nat Rev Genet 2007; 8:845-56. (Pubitemid 47609091)
113. Quintana-Murci L, Barreiro LB. The role played by natural selection on Mendelian traits in humans. Ann NY Acad Sci 2010; 1214:1-17.